Medline Inc. (MDLN) Stock Overview
Explore Medline Inc.’s financial performance, market position, analyst ratings, and future outlook.
Medline Inc. (MDLN)
Key Financials
Key Financials
Market Cap
30.9B
P/E Ratio
30.20
EPS (TTM)
$1.14
ROE
0.07%
MDLN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Medline Inc. (MDLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.62.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.20 and a market capitalization of 30.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.